← 会話に戻る
2つの英文契約条項の比較
- 日時
- 2026/10/20 12:04:22
- 最終更新
- 送信者
- Kabumoto Koji(株本 幸二) <koji.kabumoto@accrete-inc.com>
- 宛先
- Microsoft 365 Chat
- 種別
- Copilot (Microsoft 365 Chat) / bizchat / Text
- Item class
- IPM.SkypeTeams.Message.Copilot.BizChat
- 状態
- Thread ID
- 19:YtndGy7VWHMzN6ki57UsVh4FgCNRwDO71ITUqvhHVsk1@thread.v2
- Message ID
- 1792465462665
- 親Message ID
- カストディアン
- koji.kabumoto@accrete-inc.com
- 取込元
- koji.kabumoto@accrete-inc.com.001.pst / TeamsMessagesData / #3993
本文
以下の2つの文章を比較して。
Accrete's original investment in CustIntCo formed part of a broader strategic initiative to consolidate complementary artificial intelligence businesses under DAATRA, with the longer-term objective of pursuing a potential United States public-market transaction.Following subsequent developments, the parties have revisited the implementation structure of the originally contemplated consolidation. While the corporate arrangements have evolved, the underlying strategic intention to integrate CustIntCo's business capabilities, technologies and commercial activities within the broader DAATRA platform remains in place.Accordingly, the Parties agree that Accrete's original investment participation shall progress from CustIntCo to DAATRA directly, thereby maintaining Accrete's involvement in the broader strategic initiative originally contemplated.To facilitate this transition, Accrete's existing US$500,000 SAFE investment in CustIntCo, based on a US$70 million post-money valuation cap, shall be replaced by equity-linked warrant rights in DAATRA calculated by reference to the same investment amount and valuation basis.Upon the valid issuance of the agreed DAATRA warrants to Accrete, the CustIntCo SAFE shall cease to have effect, and CustIntCo shall be discharged from its obligations under the SAFE, subject to the terms of this Agreement and applicable law.This transition is intended to preserve the continuity of Accrete's strategic investment participation while reflecting the revised corporate structure of the DAATRA initiative.
---------------------------------------------------------------------------
Accrete's original investment in CustIntCo formed part of a broader strategic initiative to consolidate complementary artificial intelligence businesses under DAATRA, with the longer-term objective of pursuing a potential United States public-market transaction.Following subsequent developments, the parties have revisited the implementation structure of the originally contemplated consolidation. The underlying CustIntCo's business capabilities, technologies and commercial activities will integrate within the broader DAATRA platform while the corporate arrangements have evolved.Accordingly, the Parties agree that Accrete's original investment participation shall progress from CustIntCo to DAATRA directly, thereby maintaining Accrete's involvement in the broader strategic initiative originally contemplated.To facilitate this transition, Accrete's existing US$500,000 SAFE investment in CustIntCo, based on a US$70 million post-money valuation cap, shall be replaced by equity-linked warrant rights in DAATRA calculated by reference to the same investment amount and valuation basis.Upon the valid issuance of the agreed DAATRA warrants to Accrete, the CustIntCo SAFE shall cease to have effect, and CustIntCo shall be discharged from its obligations under the SAFE, subject to the terms of this Agreement and applicable law.This transition is intended to preserve the continuity of Accrete's strategic investment participation while reflecting the revised corporate structure of the DAATRA initiative.
元のHTML
以下の2つの文章を比較して。
<br>
Accrete's original investment in CustIntCo formed part of a broader strategic initiative to consolidate complementary artificial intelligence businesses under DAATRA, with the longer-term objective of pursuing a potential United States public-market transaction.
Following subsequent developments, the parties have revisited the implementation structure of the originally contemplated consolidation. While the corporate arrangements have evolved, the underlying strategic intention to integrate CustIntCo's business capabilities, technologies and commercial activities within the broader DAATRA platform remains in place.
Accordingly, the Parties agree that Accrete's original investment participation shall progress from CustIntCo to DAATRA directly, thereby maintaining Accrete's involvement in the broader strategic initiative originally contemplated.
To facilitate this transition, Accrete's existing US$500,000 SAFE investment in CustIntCo, based on a US$70 million post-money valuation cap, shall be replaced by equity-linked warrant rights in DAATRA calculated by reference to the same investment amount and valuation basis.
Upon the valid issuance of the agreed DAATRA warrants to Accrete, the CustIntCo SAFE shall cease to have effect, and CustIntCo shall be discharged from its obligations under the SAFE, subject to the terms of this Agreement and applicable law.
This transition is intended to preserve the continuity of Accrete's strategic investment participation while reflecting the revised corporate structure of the DAATRA initiative.
<br>
---------------------------------------------------------------------------
<br>
Accrete's original investment in CustIntCo formed part of a broader strategic initiative to consolidate complementary artificial intelligence businesses under DAATRA, with the longer-term objective of pursuing a potential United States public-market transaction.
Following subsequent developments, the parties have revisited the implementation structure of the originally contemplated consolidation. The underlying CustIntCo's business capabilities, technologies and commercial activities will integrate within the broader DAATRA platform while the corporate arrangements have evolved.
Accordingly, the Parties agree that Accrete's original investment participation shall progress from CustIntCo to DAATRA directly, thereby maintaining Accrete's involvement in the broader strategic initiative originally contemplated.
To facilitate this transition, Accrete's existing US$500,000 SAFE investment in CustIntCo, based on a US$70 million post-money valuation cap, shall be replaced by equity-linked warrant rights in DAATRA calculated by reference to the same investment amount and valuation basis.
Upon the valid issuance of the agreed DAATRA warrants to Accrete, the CustIntCo SAFE shall cease to have effect, and CustIntCo shall be discharged from its obligations under the SAFE, subject to the terms of this Agreement and applicable law.
This transition is intended to preserve the continuity of Accrete's strategic investment participation while reflecting the revised corporate structure of the DAATRA initiative.
<br>